7 stories from 5 sources
Supporting Articles
Africa’s top public health official warned the current Ebola outbreak could become the worst on record and may take up to a year to contain if transmission does not slow. Health workers say the outbreak is already among the most severe in decades and requires faster progress in flattening infection rates.
3:53 PMThe New York TimesThe Red Cross warns the Ebola outbreak in the Democratic Republic of Congo may not have peaked and could continue for up to a year. It says uncertainty about spread makes the true scale hard to determine.
8:30 AMAl JazeeraCDC data shows U.S. infant mortality fell to a record low in 2025. Even with the improvement, the U.S. still ranks worse than peer high-income countries.
10:55 AMStat NewsAn analysis of health records from nearly 60,000 adults with type 2 diabetes found semaglutide users had about 15% fewer bone fractures than people taking other common weight loss drugs. The fracture reduction appeared alongside greater weight loss in the semaglutide group.
8:07 AMScienceDailySummary
Africa’s top public health official warned the current Ebola outbreak could become the worst on record and may take up to a year to contain if transmission does not slow. Health workers say the outbreak is already among the most severe in decades and requires faster progress in flattening infection rates.
Why it matters
A prolonged Ebola outbreak increases regional spillover risk and strains fragile health systems, amplifying deaths both from Ebola and from interrupted care.
Summary
The Red Cross warns the Ebola outbreak in the Democratic Republic of Congo may not have peaked and could continue for up to a year. It says uncertainty about spread makes the true scale hard to determine.
Why it matters
A protracted Ebola outbreak increases cross-border and humanitarian risk and can collapse already fragile health services.
Summary
CDC data shows U.S. infant mortality fell to a record low in 2025. Even with the improvement, the U.S. still ranks worse than peer high-income countries.
Why it matters
A record low is progress, but the continued peer-country shortfall signals structural problems that will keep preventable infant deaths elevated without targeted reforms.
Summary
An analysis of health records from nearly 60,000 adults with type 2 diabetes found semaglutide users had about 15% fewer bone fractures than people taking other common weight loss drugs. The fracture reduction appeared alongside greater weight loss in the semaglutide group.
Why it matters
Fracture risk is a major limiter for aggressive weight loss in diabetes care, and a credible reduction could reshape prescribing and reimbursement priorities.
A curated list of other prominent stories from this day.
A Pacific nation is urging regulators to treat nicotine as a narcotic class substance rather than focusing tobacco control primarily on cigarettes. The case argues that nicotine vapes also cause harm and should fall under tighter, substance-level controls rather than product-by-product rules.
8:00 PMNatureVerge Labs is rolling out an AI model designed to improve patient stratification for neurology clinical trials by learning from past trial failures and heterogeneous patient data. The approach aims to identify more trial-ready subgroups and reduce noise that can cause promising therapies to miss endpoints.
8:00 AMStat NewsAn Alzheimer’s specialist describes failing to recognize early signs of the disease in her own father and argues Alzheimer’s is a decades-long biological process, not simply a condition of old age. She frames earlier recognition and earlier intervention as essential because symptoms arrive long after pathology begins.
4:30 AMStat NewsSummary
A Pacific nation is urging regulators to treat nicotine as a narcotic class substance rather than focusing tobacco control primarily on cigarettes. The case argues that nicotine vapes also cause harm and should fall under tighter, substance-level controls rather than product-by-product rules.
Why it matters
If nicotine is regulated like a narcotic, vaping and cessation policy could pivot globally from harm reduction via substitution to tighter demand suppression across all nicotine products.
Summary
Verge Labs is rolling out an AI model designed to improve patient stratification for neurology clinical trials by learning from past trial failures and heterogeneous patient data. The approach aims to identify more trial-ready subgroups and reduce noise that can cause promising therapies to miss endpoints.
Why it matters
Better stratification could cut neurology trial failure rates, lowering development costs and speeding effective treatments to patients.
Summary
An Alzheimer’s specialist describes failing to recognize early signs of the disease in her own father and argues Alzheimer’s is a decades-long biological process, not simply a condition of old age. She frames earlier recognition and earlier intervention as essential because symptoms arrive long after pathology begins.
Why it matters
Earlier framing changes when patients seek care and when systems must be ready to detect, treat, and plan for Alzheimer’s.
Make it yours
Pick your topics, set your cadence, and receive your personalized First Pass in your inbox. It’s that simple!